Synthesis and Antitumor Activity of 5-Bromo-7-azaindolin-2-one Derivatives Containing a 2,4-Dimethyl-1H-pyrrole-3-carboxamide Moiety

被引：7

作者：

Zhang, Jun ^{[1
,2
,3
]}

Shen, Weiyi ^{[3
]}

Li, Xiaoning ^{[1
,2
]}

Chai, Yun ^{[1
,2
]}

Li, Senjun ^{[3
]}

Lv, Kai ^{[1
,2
]}

Guo, Huiyuan ^{[1
,2
]}

Liu, Mingliang ^{[1
,2
]}

机构：

[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China

[2] Peking Union Med Coll, Beijing 100050, Peoples R China

[3] Zhejiang Starry Pharmaceut Co Ltd, Xianju 317300, Peoples R China

来源：

MOLECULES | 2016年 / 21卷 / 12期

关键词：

5-bromo-7-azaindolin-2-ones; synthesis; antitumor activity; KINASE-1; PDK1; INHIBITORS; ANTIBACTERIAL ACTIVITY; GROWTH; DESIGN;

D O I：

10.3390/molecules21121674

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report herein the design and synthesis of a series of novel 5-bromo-7-azaindolin-2-one derivatives containing a 2,4-dimethyl-1H-pyrrole-3-carboxamide moiety. These newly synthesized derivatives were evaluated for in vitro activity against selected cancer cell lines by MTT assay. Results revealed that some compounds exhibit broad-spectrum antitumor potency, and the most active compound 23p (IC50: 2.357-3.012 mu M) was found more potent than Sunitinib (IC50: 31.594-49.036 mu M) against HepG2, A549 and Skov-3, respectively.

引用

页数：10

共 19 条

[11] Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides [J].

Lv, Kai ;

Wang, Li-Li ;

Liu, Ming-Liang ;

Zhou, Xin-Bo ;

Fan, Shi-Yong ;

Liu, Hong-Ying ;

Zheng, Zhi-Bing ;

Li, Song .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) :3062-3065

[12] Early amidation approach to 3-[(4-amido)pyrrol-2-yl]-2-indolinones [J].

Manley, JM ;

Kalman, MJ ;

Conway, BG ;

Ball, CC ;

Havens, JL ;

Vaidyanathan, R .

JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (16) :6447-6450

[13]

Norden Andrew D, 2007, Neurosurg Focus, V23, pE12, DOI 10.3171/foc.2007.23.4.13

[14] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer [J].

Novello, S. ;

Scagliotti, G. V. ;

Rosell, R. ;

Socinski, M. A. ;

Brahmer, J. ;

Atkins, J. ;

Pallares, C. ;

Burgess, R. ;

Tye, L. ;

Selaru, P. ;

Wang, E. ;

Chao, R. ;

Govindan, R. .

BRITISH JOURNAL OF CANCER, 2009, 101 (09) :1543-1548

[15] Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase [J].

Sun, L ;

Liang, C ;

Shirazian, S ;

Zhou, Y ;

Miller, T ;

Cui, J ;

Fukuda, JY ;

Chu, JY ;

Nematalla, A ;

Wang, XY ;

Chen, H ;

Sistla, A ;

Luu, TC ;

Tang, F ;

Wei, J ;

Tang, C .

JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1116-1119

[16] Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents [J].

Tang, Jian ;

Wang, Bangxing ;

Wu, Tian ;

Wan, Junting ;

Tu, Zhengchao ;

Njire, Moses ;

Wan, Baojie ;

Franzblauc, Scott G. ;

Zhang, Tianyu ;

Lu, Xiaoyun ;

Ding, Ke .

ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07) :814-818

[17]

Tang P. C., 2010, J MED CHEM, V53, P8140, DOI DOI 10.1021/JM101036C

[18] Synthesis and antitumor activity of 5-(5-halogenated-2-oxo-1H-pyrrolo[2,3-b]pyridin-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamides [J].

Wang, Minghua ;

Ye, Cheng ;

Liu, Mingliang ;

Wu, Zhaoyang ;

Li, Linhu ;

Wang, Chunlan ;

Liu, Xiujun ;

Guo, Huiyuan .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (14) :2782-2787

[19]

Wang Xiu-yun, 2008, Yaoxue Xuebao, V43, P819

← 1 2 →